Lord, Abbett & Co
BLUE

Lord, Abbett & Co’s bluebird bio BLUE Stock Holding History

Lord, Abbett & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-22,308
Closed -$49.3M – 852
2018
Q1 		$49.3M Sell
22,308
-5,305
-19% -$13.5M 0.15% 213
2017
Q4 		$63.7M Buy
27,613
+8,508
+45% +$17.3M 0.18% 173
2017
Q3 		$34M Buy
+19,105
New +$26.7M 0.1% 332
2017
Q2 		– Sell
-5,452
Closed -$6.42M – 881
2017
Q1 		$6.42M Buy
+5,452
New +$5.56M 0.02% 705
2015
Q4 		– Sell
-15,401
Closed -$17.1M – 888
2015
Q3 		$17.1M Sell
15,401
-31,292
-67% -$57.1M 0.05% 467
2015
Q2 		$102M Sell
46,693
-11,452
-20% -$23.3M 0.27% 81
2015
Q1 		$91M Buy
58,145
+23,464
+68% +$31M 0.23% 107
2014
Q4 		$41.2M Buy
34,681
+18,448
+114% +$12.3M 0.1% 272
2014
Q3 		$7.54M Buy
16,233
+7,040
+77% +$3.25M 0.02% 656
2014
Q2 		$4.59M Buy
+9,193
New +$2.95M 0.01% 818

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co's BLUE Position: Q2 2018 in Review

Lord, Abbett & Co sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 22,308 shares — an estimated $49.3M sold.

Lord, Abbett & Co first reported a position in BLUE in Q2 2014 and held it in 10 quarters. The position peaked at $102M in Q2 2015. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

  • Lord, Abbett & Co reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 22,308 bluebird bio shares in Q2 2018, an estimated $49.3M.
  • Lord, Abbett & Co first reported a position in bluebird bio in Q2 2014 and held it in 10 quarters.
  • Lord, Abbett & Co's bluebird bio position peaked at $102M in Q2 2015.
  • 307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Lord, Abbett & Co's 13F filing for Q2 2018, filed 14 Aug 2018.